Rezolute (RZLT) Reiterated at Neutral by Cantor Fitzgerald After FDA Meeting
Tweet Send to a Friend
Cantor Fitzgerald analyst Pete Stavropoulos reiterated a Neutral rating on Rezolute (NASDAQ: RZLT).The analyst commented, "We caught up with RZLT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


